These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 30243113

  • 1. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
    Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Skrzydlewska E.
    Adv Med Sci; 2019 Mar; 64(1):15-23. PubMed ID: 30243113
    [Abstract] [Full Text] [Related]

  • 2. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
    Biernacki M, Łuczaj W, Gęgotek A, Toczek M, Bielawska K, Skrzydlewska E.
    Toxicol Appl Pharmacol; 2016 Jun 15; 301():31-41. PubMed ID: 27086176
    [Abstract] [Full Text] [Related]

  • 3. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
    Biernacki M, Ambrożewicz E, Gęgotek A, Toczek M, Bielawska K, Skrzydlewska E.
    Redox Biol; 2018 May 15; 15():41-50. PubMed ID: 29197803
    [Abstract] [Full Text] [Related]

  • 4. The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension.
    Biernacki M, Baranowska-Kuczko M, Niklińska GN, Skrzydlewska E.
    Biomolecules; 2020 Jul 10; 10(7):. PubMed ID: 32664225
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
    Biernacki M, Malinowska B, Timoszuk M, Toczek M, Jastrząb A, Remiszewski P, Skrzydlewska E.
    Prostaglandins Other Lipid Mediat; 2018 Sep 10; 138():54-63. PubMed ID: 30201316
    [Abstract] [Full Text] [Related]

  • 7. Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor.
    Dobrzyńska I, Szachowicz-Petelska B, Weresa J, Figaszewski ZA, Skrzydlewska E.
    Chem Biol Interact; 2019 Feb 01; 299():52-58. PubMed ID: 30502333
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Karpińska O, Toczek M, Harasim E, Kasacka I, Malinowska B.
    Life Sci; 2016 Apr 15; 151():288-299. PubMed ID: 26969765
    [Abstract] [Full Text] [Related]

  • 10. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Harasim-Symbor E, Biernacki M, Kasacka I, Malinowska B.
    Int J Mol Sci; 2021 May 02; 22(9):. PubMed ID: 34063297
    [Abstract] [Full Text] [Related]

  • 11. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
    Pędzińska-Betiuk A, Weresa J, Toczek M, Baranowska-Kuczko M, Kasacka I, Harasim-Symbor E, Malinowska B.
    Br J Pharmacol; 2017 Jul 02; 174(13):2114-2129. PubMed ID: 28437860
    [Abstract] [Full Text] [Related]

  • 12. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety.
    Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D.
    Psychopharmacology (Berl); 2018 Nov 02; 235(11):3211-3221. PubMed ID: 30251159
    [Abstract] [Full Text] [Related]

  • 13. URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats.
    Hasanein P, Parviz M, Keshavarz M, Roohbakhsh A.
    Can J Physiol Pharmacol; 2009 Jun 02; 87(6):432-9. PubMed ID: 19526037
    [Abstract] [Full Text] [Related]

  • 14. The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB₁- and FAAH-independent mechanisms.
    Bosier B, Muccioli GG, Lambert DM.
    Br J Pharmacol; 2013 Jun 02; 169(4):794-807. PubMed ID: 22970888
    [Abstract] [Full Text] [Related]

  • 15. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN, Norris LM, Woodhams S, Burston J, Patel A, Alexander SP, Barrett DA, Kendall DA, Bennett AJ, Chapman V.
    Br J Pharmacol; 2012 Oct 02; 167(3):627-40. PubMed ID: 22595021
    [Abstract] [Full Text] [Related]

  • 16. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.
    Toczek M, Baranowska-Kuczko M, Grzęda E, Pędzińska-Betiuk A, Weresa J, Malinowska B.
    Pharmacol Rep; 2016 Apr 02; 68(2):363-9. PubMed ID: 26922540
    [Abstract] [Full Text] [Related]

  • 17. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 02; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress.
    Bortolato M, Mangieri RA, Fu J, Kim JH, Arguello O, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    Biol Psychiatry; 2007 Nov 15; 62(10):1103-10. PubMed ID: 17511970
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
    Li H, Wood JT, Whitten KM, Vadivel SK, Seng S, Makriyannis A, Avraham HK.
    Br J Pharmacol; 2013 Oct 15; 170(3):489-505. PubMed ID: 23347118
    [Abstract] [Full Text] [Related]

  • 20. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
    Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW.
    Br J Pharmacol; 2006 Feb 15; 147(3):281-8. PubMed ID: 16331291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.